Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2019
09-05-19 kl. 9/5 2019 14:22 | Novo Nordisk A/s 46,52 (+0,65%)
Se flere nyheder om Novo Nordisk A/s
Bagsværd, Denmark, 9 May 2019 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse.
The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons.
Further information
| Media: | ||
| Mette Kruse Danielsen | +45 4442 3883 | [email protected] |
| Ken Inchausti (US) | +1 609 240 9429 | [email protected] |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | [email protected] |
| Valdemar Borum Svarrer | +45 3079 0301 | [email protected] |
| Ann Søndermølle Rendbæk | +45 3075 2253 | [email protected] |
| Kristoffer Due Berg (US) | +1 609 235 2989 | [email protected] |
Company announcement No 33 / 2019
Company announcement No 33 / 2019
May 9, 2019
Der er endnu ikke skrevet nogen kommentarer til denne artikel.
Skriv en kommentarer til denne artikel:
Send kommentar
Skriv en kommentarer til denne artikel:
Send kommentar
| PRIS | 46,52 |
|---|---|
| ÆNDRING | +0,30 (+0,65%) |
| ÅBEN | 46,47 |
| SIDSTE LUK | 0,00 |
| DEBAT | - |
 |
